Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Napo Pharms drug MYTESI appeared first on DrugPate…
New patent expiration for Napo Pharms drug MYTESI Read Post »
Annual Drug Patent Expirations for YOSPRALA Yosprala is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Genus Lifesciences drug YOSPRALA ap…
New patent expiration for Genus Lifesciences drug YOSPRALA Read Post »
Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Horizon drug VIMOVO appeared first on Dr…
VIMOVO (esomeprazole magnesium; naproxen) Horizon Patent: 8,852,636 Expiration: May 31, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The po…
Drug Patent Expirations for the Week of May 29, 2022 Read Post »
Annual Drug Patent Expirations for ADVIL+PM Advil Pm is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from four suppliers. There are three patents…
The post New patent expiration for Glaxosmithkline drug ADVIL PM appea…
New patent expiration for Glaxosmithkline drug ADVIL PM Read Post »
Annual Drug Patent Expirations for RYTARY Rytary is a drug marketed by Impax Labs Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Impax Labs drug RYTARY appeared first on DrugPatentW…
New patent expiration for Impax Labs drug RYTARY Read Post »
Annual Drug Patent Expirations for RYTARY Rytary is a drug marketed by Impax Labs Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent expiration for Impax Labs drug RYTARY appeared first on DrugPatentW…
New patent expiration for Impax Labs drug RYTARY Read Post »
Annual Drug Patent Expirations for PEMFEXY Pemfexy is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Eagle Pharms drug PEMFEXY appeared first on D…
New patent expiration for Eagle Pharms drug PEMFEXY Read Post »
Annual Drug Patent Expirations for ALIMTA Alimta is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for LILLY drug ALIMTA appeared first on DrugPaten…
PEMFEXY (pemetrexed) Eagle pharms Patent: 7,772,209 Expiration: May 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Paten…
Drug Patent Expirations for the Week of May 22, 2022 Read Post »